Non-thermal pain-relieving lasers from ERCHONIA focus on photochemical stimulation to promote healing and pain relief without generating heat, which distinguishes them from infrared lasers, which primarily rely on thermal effects to achieve therapeutic results. This difference in approach affects their safety, application, and the specific benefits they offer in clinical settings. 

Non-thermal lasers emit light at specific wavelengths, using red, green, and violet light. They promote the release of nitric oxide, a signaling molecule that improves blood circulation, reduces inflammation, and facilitates cellular communication.

 The photobiomodulation of ERCHONIA lasers influences the expression of genes related to cell proliferation, migration, and anti-inflammatory responses, thus contributing to tissue repair and the reduction of inflammation. 

Their non-thermal effects make them safer for direct application on the skin without the risk of burns or tissue overheating. 

ERCHONIA lasers have been FDA-approved in the USA for various indications, including nociceptive musculoskeletal pain, chronic lower back pain, neck and shoulder pain, chronic plantar fasciitis, and postoperative pain, highlighting their effectiveness and safety in clinical use.

• They stimulate mitochondria by improving the function of the cell's cytochrome c oxidase
• Lead to an increase in ATP production
• Allow a reduction in oxidative stress
• Improve nitric oxide signaling
• Create beneficial changes in gene expression
• Promote cellular energy production
• Reduce inflammation
• Accelerate healing processes
• Increase performance
• Results supported by more controlled studies than any other company.